ACAndrea CalcagnoMD, DTM&HSlidesetHIVChinese HIV Clinical Forum Educational Series 2020 - 2021State of the Art: Clinical Pharmacology of INSTI - Andrea CalcagnoView Slideset
FVFrançois VenterMD, FCP, PhDVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Adherence Considerations in Choice of ARV Regimens - Francois VenterView Video
ACAndrea CalcagnoMD, DTM&HVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021State of the Art: Clinical Pharmacology of INSTI - Andrea CalcagnoView Video
CYChia-Jui YangMDVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Recap the Second EditionView Video
KRKiat RuxrungthamMDSlidesetHIVChinese HIV Clinical Forum Educational Series 2020 - 2021HIV Drug Resistance in Asia Clinical Application - Kiat Ruxrungtham, MDView Slideset
CYChia-Jui YangMDSlidesetHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Optimal use of DTG in treatment experienced patients - Chia-Jui YangView Slideset
AMAnne-Geneviève MarcelinMDSlidesetHIVChinese HIV Clinical Forum Educational Series 2020 - 2021State of the Art Resistance to INSTI - Anne - Geneviève MarcelinView Slideset
VideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Roundtable Discussion: Resistance Considerations in Optimal Use of INSTIView Video
KRKiat RuxrungthamMDVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021HIV Drug Resistance in Asia Clinical Application - Kiat Ruxrungtham, MDView Video
CYChia-Jui YangMDVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Optimal Use of DTG in Treatment Experienced Patients - Chia-Jui Yang, MDView Video
AMAnne-Geneviève MarcelinMDVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021State of the Art: Resistance to INSTI - Anne - Geneviève Marcelin, PharmD, PhDView Video
VideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Roundtable Discussion: Benefits of 2nd Generation INSTI in Routine Clinical PracticeView Video
